Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Antonio F Caballero-Bermejo"'
Autor:
Ignacio Darnaude-Ximénez, Antonio F Caballero-Bermejo, Belén Ruiz-Antorán, Myriam Aguilar-Pérez, Alicia Gómez-López, Aranzazu Sancho-López, Cristian García-Fadul, Elena Diago-Sempere, Manuel Valle Falcones, Piedad Ussetti-Gil, Cristina Avendaño-Solá
Publikováno v:
JMIR Research Protocols, Vol 11, Iss 9, p e37275 (2022)
BackgroundAspergillosis is the most frequently observed invasive fungal disease (IFD) in lung transplant recipients. Isavuconazole (ISA) has shown a better safety profile and noninferiority to voriconazole in the treatment of patients with IFD. Obje
Externí odkaz:
https://doaj.org/article/ad7b452043234a94aec8e2f59f0eb624
Autor:
Verónica Polaino Moreno, Antonio F. Caballero-Bermejo, Mariano Artés Caselles, Javier Serrano González, Xabier Remírez Arriaga, Natalia González Alcolea, Aritz Equisoain Azcona, Eva Iglesias García, José Luis Lucena de la Poza, Arsenio Sánchez Movilla, Belén Ruiz-Antorán, PERIQxA Study Group
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-7 (2024)
Abstract Background Anorectal fistula, which is a relatively common pathology, is the chronic manifestation of the acute perirectal process that forms an anal abscess. The development of a fistula after incision and drainage of an anal abscess is see
Externí odkaz:
https://doaj.org/article/073a97c8775549a9ad44b0c050cd302c
Autor:
Antonio F. Caballero Bermejo, Belén Ruiz-Antorán, Ana Fernández Cruz, Elena Diago Sempere, Alejandro Callejas Díaz, Elena Múñez Rubio, Cristina Avendaño-Solá, Antonio Ramos Martínez, Aránzazu Sancho López, Puerta de Hierro COVID-19 Study Group
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Abstract Objectives In some patients, acute, life-threatening respiratory injury produced by viruses such as SARS-CoV and other viral pneumonia are associated with an over-exuberant cytokine release. Elevated levels of blood IL-6 had been identified
Externí odkaz:
https://doaj.org/article/4444ddda56584542a5ada9f5bfcd20d7
Autor:
Ignacio Darnaude-Ximénez, Antonio F Caballero-Bermejo, Belén Ruiz-Antorán, Myriam Aguilar-Pérez, Alicia Gómez-López, Aranzazu Sancho-López, Cristian García-Fadul, Elena Diago-Sempere, Manuel Valle-Falconés, Piedad Ussetti-Gil, Cristina Avendaño-Solá
BACKGROUND Aspergillosis is the most frequently observed invasive fungal disease (IFD) in lung transplant recipients. Isavuconazole has shown a better safety profile and non-inferiority to voriconazole in the treatment of patients with IFD. OBJECTIVE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fc90ca931664776200d5d95f815f293
https://doi.org/10.2196/preprints.37275
https://doi.org/10.2196/preprints.37275
Autor:
Aránzazu, Sancho-López, Antonio F, Caballero-Bermejo, Belén, Ruiz-Antorán, Elena, Múñez Rubio, Mercedes, García Gasalla, Juan, Buades, Marta, González Rozas, María, López Veloso, Ana, Muñoz Gómez, Ana, Cuenca Abarca, Pedro, Durán Del Campo, Fátima, Ibáñez, Alberto, Díaz de Santiago, Yolanda, Romero, Jorge, Calderón, Ilduara, Pintos, Adrián, Ferre Beltrán, Gustavo, Centeno Soto, José, Campos, Antonio, Ramos Martínez, Cristina, Avendaño-Solá, Ana, Fernández Cruz, Fuencisla Gómez, Ruiz
Publikováno v:
Infectious Diseases and Therapy
Introduction SARS-CoV-2 pneumonia is often associated with hyper-inflammation. The cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 (COVID-19). High Interleukin-6 (IL6) blood levels have been identified in s